MyoKardia

MYOK NASDAQ
46.66
-0.76
-1.60%
交易中 14:28 06/24 EDT
开盘
47.64
昨收
47.42
最高
47.64
最低
46.27
成交量
10.40万
成交均量(3M)
44.90万
52周最高
67.79
52周最低
39.01
换手率
0.23%
市值
21.50亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供MyoKardia MYOK股票价格,MyoKardia股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. The Company is engaged in the business of developing and commercializing therapeutics. The Company has used its precision medicine platform to generate an initial pipeline of over four therapeutic programs for the chronic treatment of two forms of heritable cardiomyopathy-hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (DCM). Additionally, the Company has three preclinical programs, HCM-2, DCM-2 and LUS-1. Its lead product candidate, MYK-461, is an orally-administered small molecule designed to reduce excessive cardiac muscle contractility leading to HCM.
展开 >

最近浏览

名称
价格
涨跌幅